Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
12/09/2025
SOL's market value has exceeded $126 billion, setting a new historical high, surpassing BNB and becoming the fifth largest cryptocurrency by market value.
Latest
1 m ago
KPMG's 2025 Government Policy Report suggests considering the introduction of a fractional share trading system and increasing after-hours trading.
3 m ago
CMB International Securities: Target price for Cheesecake City Technology (09911.HK) is 16.2 Hong Kong dollars, expected to maintain strong momentum.
3 m ago
AstraZeneca's long-acting C5 complement inhibitor Ultomiris has been launched in China.
3 m ago
AstraZeneca announces that the long-acting C5 complement inhibitor Ultomiris (generic name: ravulizumab injection) has been officially launched in China for use in combination with conventional treatment drugs for the treatment of adult generalized myasthenia gravis (gMG) patients who are positive for anti-acetylcholine receptor (AChR) antibodies, as well as for the treatment of adult neuromyelitis optica spectrum disorder (NMOSD) patients who are positive for anti-aquaporin-4 (AQP4) antibodies.
4 m ago
Stock anomaly in Hong Kong | Brainstorm Aurora (06681.HK) surged over 50% to a new high, recently included in the Hong Kong Stock Connect list, core pipeline made significant progress.
See all latest